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Edited by Giulio Superti-FurgaAbstract Tyk2 deﬁcient mice show a markedly reduced suscep-
tibility to lipopolysaccharide (LPS) induced shock and a partial
impairment of IL-12 and interferon (IFN) signals. To examine
the underlying mechanisms, we analysed the activation of perito-
neal macrophages (PMUs) and spleen cells after LPS challenge.
In PMUs and spleen cells the contribution of Tyk2 to the induc-
tion of the T-cell co-stimulatory molecules CD86, CD40 and
MHC II was small or insigniﬁcant. By contrast, induced expres-
sion of the early activation marker CD69 on PMUs and splenic
cell populations required type I interferons (IFN-I) and Tyk2.
The data suggest a selective contribution of Tyk2 to the activa-
tion of inﬂammation-relevant cell types by LPS.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Lipopolysaccharide (LPS) is a component of the outer mem-
brane of Gram-negative bacteria and functions as an essential
pattern for the recognition of invading pathogens by the host.
Mammalian cells bind LPS through the Toll-like receptor
(TLR) 4 signalling complex, which activates cells of the innate
and adaptive immune system to engage in anti-bacterial defence
[1]. Upon extensive or systemic exposure to LPS the host reacts
with systemic inﬂammation and septic shock mediated through
dysregulated pro-inﬂammatory cytokines and mediators [2].
The essential role of the LPS–TLR4 signalling cascade in the
LPS-induced septic shock syndrome was emphasized by studies
in mice carrying spontaneous, induced or targeted mutations in
genes contributing to the pathway [3–5]. Disruption of the
TLR4 signalling complex causes hypo-responsiveness to LPS
and enhanced resistance to the endotoxin shock. Tumor necro-
sis factor alpha (TNFa) is an important mediator of the LPS-
endotoxicity [6]. In addition, interferons (IFNs) and their signalAbbreviations: LPS, lipopolysaccharide; TLR, Toll-like receptor;
Tyk2, tyrosine kinase 2; Ifnar, interferon type I receptor; IFN,
interferon; IL, interleukin; PMUs, peritoneal macrophages; DC,
dendritic cell; NK cell, natural killer cell; MUs, macrophages; FACS,
ﬂuorescence activated cell sorting
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mice deﬁcient for IFNb, IFN-c-receptor, signal transducer
and activator of transcription (Stat) 1, 4 or the tyrosine kinase
2 (Tyk2) show various degrees of LPS resistance [8–10]. Tyk2, a
member of the Janus kinase (Jak) family, contributes to signal
transduction by various cytokine receptors including those for
IFN-I, interleukin (IL)-6, IL-10, IL-12 and IL-23. In previous
studies we described an impairment of cytokine production/re-
sponses in LPS-treated, Tyk2 deﬁcient mice and cells, resulting
in endotoxin hyposensitivity [8,11]. Macrophages (MUs),
hematopoietic precursors and spleen cells are of primary impor-
tance for the recognition of LPS and/or the emerging and devel-
opment of LPS toxicity [2]. Here we examined the activation of
peritoneal macrophages (PMUs) and spleen cells by LPS in ab-
sence of Tyk2 or the IFN-I receptor.2. Materials and methods
2.1. Mice
Eight to twelve-week-old male C57BL/6 mice were purchased from
Charles River Laboratories. Age- and sex-matched homozygous mu-
tants of the lines B6.129P2-Tyk2tm1 (Tyk2/) [12], B6.129P2-If-
nar1tm1 (Ifnar1/) [13], B6.129P2-Ifnartm1 (Ifnar2/) [14] and
B6.129P2-Ifnbtm1 (IFNb/) [15] were bred and housed in the speciﬁc
pathogen free facility of Biomodels Austria according to FELASA
guidelines. All animal experiments were discussed and approved by
the institutional ethics committee and were carried out in accordance
with protocols approved by the Austrian Laws (GZ 68.205/67-BrGT/
2003; GZ 68.205/0204-C/GT/2007) and European Directives.
2.2. Preparation and culture of peritoneal macrophages (PMUs)
Thioglycolate (Sigma–Aldrich)-elicited PMUs were harvested as pre-
viously described [16]. Cells were cultured under standard conditions
(37 C, 5% CO2, humidiﬁed atmosphere) in six well non-cell culture
dishes (Greiner) for ﬂuorescence activated cell sorting (FACS) analysis
and six well cell culture dishes (BD Falcon) for RNA analysis, respec-
tively, by using Dulbeccos Modiﬁed Eagles Medium (DMEM) (Invit-
rogen) supplemented with 5% fetal calf serum (FCS), 100 mg/ml
penicillin, 100 U/ml streptomycin, 2 mM L-glutamine and 50 lM b-
mercaptoethanol. Cells were stimulated either with 100 ng/ml LPS (de-
rived from Escherichia coli serotype 055:B5) (Sigma–Aldrich) accord-
ing to previously published data [8,10] or 100 U/ml IFNb
(Calbiochem) at indicated time points. For FACS analysis, MUs were
detached by incubating in ice cold phosphate-buﬀered saline (PBS)/
15 mM EDTA at 4 C, collected by gently pipetting up and down
and resuspended in Hanks Buﬀered Salt Solution (HBSS)/25 mM
HEPES, 5 mM MgCl2, 0.1% BSA.
2.3. Preparation of spleen cells
Prior to cell isolation mice were injected intraperitoneally with LPS
(Escherichia coli serotype 055:B5; 50 mg/kg body weight) (Sigma–Al-
drich) according to previously published survival studies [8,10]. Afterblished by Elsevier B.V. All rights reserved.
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the tissue through a cell strainer (BD Falcon) subsequent to an enzy-
matic digestion with Collagenase D (0.5 mg/ml) and DNAseI
(0.025 mg/ml) (Roche) in RPMI 1640 (Invitrogen). Cell fractions were
isolated by density gradient using Lympholyte-M (Cedarlane)
according to manufacturers protocol.
2.4. Flow cytometry
To minimize non-speciﬁc binding, cells were pre-incubated with anti-
CD16/32 (Fcc III/II Receptor) and 5% aggregated rat serum. For mul-
ticolour surface phenotyping 2.5 · 105 PMUs and up to 1 · 106 spleen
cells per reaction were incubated with following monoclonal antibod-
ies: anti-CD4, anti-CD8a, anti-CD11b (Mac-1), anti-CD11c, anti-
CD19, anti-CD40, anti-CD45R/B220, anti-CD69, anti-CD86 (B7-2),
anti-I-A/I-E (MHC II), and anti-NK1.1, directly conjugated to ﬂuoro-
chromes (ﬂuorescein isothiocyanate (FITC), phycoerythrin (PE), allo-
phycocyanin (APC), Paciﬁc Blue, Alexa Fluor 488, peridinin-
chlorophyll-protein complex (PerCP)-Cy5.5 or PE-Cy7) all purchased
from either BD Biosciences or BioLegend. The following lineage mark-
ers were used to distinguish deﬁned cell populations: CD4 – helper T-
cells, CD8 – cytotoxic T-cells, B220 – B-cells, NK1.1 – natural killer
(NK) cells, CD11c/MHC II – mature dendritic cells (DCs) and
CD11b – MUs. For analysis at least 20000 cells were acquired using
a BD FACSAria Flow Cytometer (BD Biosciences) and data were ana-
lysed with FACSDiva 5.0.2 (BD Biosciences).
2.5. Preparation of RNA and quantitative real-time PCR (qPCR)
Total RNA was isolated with TRIzol Reagent (Invitrogen). RNA
was treated with RQ1 RNase-Free DNase (Promega) and reverse tran-
scribed using iScript cDNA synthesis kit (Biorad). All protocols were
performed following the manufacturers recommendations. For Taq-
Man real-time PCR, a standard reaction contained 2 ll cDNA,
4 mM MgCl2, 300 nM primers (Invitrogen), 100 nM probe (Metabi-
on), 1U HOT FIREPol, 1· PCR reaction buﬀer B (Solis BioDyne),
200 lM dNTP mix. Ampliﬁcation was performed by an initial denatur-
ation step at 95 C for 15 min followed by 45 cycles at 95 C for 30 s
and 60 C for 1 min on an ABI PRISM 7700 (Applied Biosystems).
For the detection of expression of CD69, primers and probe from a
previously published assay were used [17]. Sample values were normal-
ized to the expression of the housekeeping gene ubiquitin-conjugating
enzyme E2D2 (UBE2D2) using the primers: UBE2D2forward 5 0-AGGFig. 1. (A–C) FACS analyses of CD69 expression on peritoneal macropha
percentage of CD69+ cells is given in the plot panels. Untreated (0 h) and LPS
induction of CD69+ cells in the respective genotypes following stimulation w
analysis of relative CD69 mRNA expression in PMs upon LPS stimulation
means ± S.E.M. and represent at least three independent experiments. For
genotype were analysed. Signiﬁcance is indicated as: *P < 0.05, **P < 0.01, **
Tyk2/.TCC TGT TGG AGA TGA TAT GTT-3 0, UBE2D2reverse 5 0-TTG
GGA AAT GAA TTG TCA AGA AA-3 0 and the probe FAM-CCA
AAT GAC AGC CCC TAT CAG GGT GG-BHQ-1.
2.6. Statistical analysis
Results are presented as means ± S.E.M. and are representative of at
least three independent experiments. Diﬀerences between groups were
determined by univariate ANOVA analysis using SPSS for Windows
14.0 software. A P-value less than 0.05 denoted the presence of a sta-
tistically signiﬁcant diﬀerence with the following degrees: *P < 0.05;
**P < 0.01; ***P < 0.001.3. Results and discussion
3.1. Expression of CD69 in LPS-treated PMUs requires Tyk2
and signalling through the IFN-I receptor
To study the immediate response of Tyk2 deﬁcient PMUs
the cells were stimulated with LPS over a period of 24 h and
the expression of the early activation cell surface marker
CD69 was measured by FACS analysis. CD69 is a member
of the C-type lectin family and is rapidly upregulated by vari-
ous stimuli, including IFN-I, in most cells of the innate and ac-
quired immune system [17,18]. An increase of CD69+ cells was
evident in wild-type PMUs 6 h after stimulation and peak val-
ues were reached at 12 h with approximately 50% positive cells
(Fig. 1A). Beyond 12 h stimulation CD69+ PMUs rapidly de-
clined. The numbers of untreated CD69+ Tyk2/ PMUs
were comparable to wild-type cells, however, reduced numbers
of CD69+ Tyk2 deﬁcient cells were observed after LPS stimu-
lation. Upregulation of CD69 in LPS-treated PMUs deﬁcient
for Ifnar1, Ifnar2 and IFNb was almost completely abolished
(Fig. 1A and B). Stimulation of PMUs with IFNb alone re-
vealed that up-regulation of CD69+ cells was partially depen-
dent on Tyk2 and, as expected, completely dependent on
Ifnar1 (Fig. 1C). The expression of CD69 mRNA upon LPSges, PMUs (PMs). (A) Dot plot analysis of CD11b+ gated PMs. The
(100 ng/ml) stimulated cells (12h) are shown. (B, C) Time-course of the
ith LPS (100 ng/ml) and IFNb (100 U/ml), respectively. (D) Real-time
(100 ng/ml). Values were calibrated to Wt 0 h. Data are presented as
each experiment at least two pools (two-three animals per pool) per
*P < 0.001; *P Tyk2/ compared to Wt, +P Ifnar1/ compared to
A. Schneider et al. / FEBS Letters 582 (2008) 3681–3686 3683treatment was clearly diminished in Tyk2/ PMUs and
nearly absent in Ifnar1/ PMUs suggesting impaired tran-
scription as a major cause of the reduced cell surface expres-
sion of CD69 in the mutant genotypes (Fig. 1D).
Nevertheless, post-transcriptional modiﬁcations contributing
to the aberrant mutant cell surface expression patterns cannotFig. 2. FACS analyses of CD69 expression on spleen cells after LPS challen
cells. The percentage of CD4+CD69+ T-cells is given in the plot panels. (B)
CD11c+MHC II+ DCs, NK1.1+ NK-cells and CD11b+ macrophages at in
Tyk2/, white columns; Ifnar1/, grey columns. (C) Dot plot analysis of
cells is given in the plot panels. Cells of untreated (0 h) and LPS treated mice
least three independent experiments, each with two mice per time-point andbe excluded. Taken together, IFNb and interferon type I
receptor (Ifnar) are both essential for the increased expression
of CD69 in PMUs upon LPS treatment. Absence of Tyk2
causes a partial reduction of the LPS/IFN-I eﬀect on CD69
expression in accordance with the previously described partial
requirement of Tyk2 for IFN-I responses [12,19].ge (50 mg/kg). (A) Dot plot analysis of spleen cells gated for CD4+ T-
Time-course of the induction of CD69+ cells gated on CD4+ T-cells,
dicated time-points for the respective genotypes: Wt, black columns;
spleen cells gated for B220+ B-cells. The percentage of B220+CD69+ B-
at the indicated time-points are shown. Results are presented from at
genotype. For statistical analysis see legend of Fig. 1.
Fig. 3. (A–D) FACS analyses of CD86 expression. (A, C) Dot plot analyses of CD11b+ gated peritoneal macrophages, PMUs (PMs) and B220+
gated B-cells. Cells of untreated (0 h) and LPS (50 mg/kg) treated mice (12 h) are shown. The percentage of CD11b+CD86+ PMs and B220+CD86+ B-
cells respectively is given in the plot panels. (B, D) Time-course of the induction of CD86+ cells gated on CD11b+ PMs and B220+ B-cells respectively
at indicated time-points for the respective genotypes: Wt, black columns; Tyk2/, white columns; Ifnar1/, grey columns. (E, F) Time-course of
the induction of CD40+ cells gated on (E) B220+ B-cells and (F) CD11b+ PMs, respectively. (G) Time-course of the induction of MHC II+ cells gated
on CD11b+ PMs. For experimental procedures and statistical analysis see legends of Fig. 1 and Fig. 2.
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spleen of LPS-treated mice
Next we analysed spleen cells of LPS-treated mice for early
activation markers. Spleen-derived T-cells, DCs, NK cells and
MUs showed an increase of CD69+ cells in all genotypes. With
the exception of B-cells, however, all cell types from Tyk2/
and Ifnar1/ spleens showed a clear reduction in the number
of CD69+ cells throughout the whole time-course of stimula-
tion (Fig. 2A and B). Signiﬁcant diﬀerences between the num-
bers of CD69+ Tyk2/ and Ifnar1/ cells were found only
at the earliest time-point after treatment, with T-cells from
Ifnar1/ animals expressing lower levels of CD69
(Fig. 2B). The diﬀerence between Tyk2/ and wild-type
was most evident for CD4+ and CD8+ T-cells, DCs and
MUs and less pronounced for NK cells (Fig. 2A and B and
data not shown). In B-cells the increase of CD69+ cells was de-
layed in Tyk2/ and Ifnar1/, but reached wild-type levels
at 12 h post-stimulation (Fig. 2C and data not shown).
Contrasting PMUs, Tyk2 and Ifnar1 deﬁciency had similar
and partial eﬀects on LPS-induced CD69 expression in all
spleen cell populations with the exception of B-cells. The in-
crease of CD69+ cells in the absence of Ifnar1 can be explained
by co-stimulatory factors and cellular cross-talk in whole or-
gans and/or co-culture conditions. Consistent with this notion,
upregulation of CD69 by LPS in T-cells is stimulated by co-
culture with MUs in a complement receptor dependent manner
[20]. The early activation of B-cells is unaﬀected by the lack of
IFN-I signalling. Instead, direct interaction with T-cells and
the presence of an additional B-cell speciﬁc LPS receptor
(RP105/CD180) are responsible for the LPS-induced increase
in CD69 expression in this cell type [21,22].
3.3. Involvement of Tyk2 in LPS-mediated upregulation of
CD86 on PMUs and B-cells
The initiation of the adaptive immune response depends on
co-stimulatory surface molecules such as CD86 (B7-2) and
CD40, which are expressed by antigen presenting cells and help
to activate T-cells that are exposed to antigen in the context of
major histocompatibility complex (MHC) proteins. Consistent
with previous reports showing that upregulation of CD86 in
LPS-treated PMUs requires TRIF mediated IFN-I synthesis
and signalling, CD86 expression on these cells was reduced
in absence of Ifnar1 ([23] and Fig. 3A and B). Numbers of
CD86+ PMUs were reduced in absence of Tyk2 or Ifnar1 both
in untreated cells and in cells after treatment with LPS for 6 h.
At later time points, however, Tyk2/ PMUs nearly matched
the wild-type situation indicating that the participation of
Tyk2 to the IFN-I response is less crucial for the increase in
LPS-mediated CD86 expression (Fig. 3A and B). Neither If-
nar1 (see also [24]) nor Tyk2 were required for the LPS-in-
duced increase of CD86+ B-cells (Fig. 3C and D), which is in
accordance with the demonstration of an Ifnar-independent
alternate pathway of B-cell activation by LPS [21,22].
Upregulation of CD40 and MHC II in PMUs and B-cells
was completely independent of Tyk2 (Fig. 3E–G). This is in
line with previous ﬁndings that T-cell co-stimulatory molecule
induction in spleen cells by various stimuli is widely unaﬀected
by defects in IFN-I signals [19,24,25].
Taken together, we demonstrate a clear Tyk2 requirement
for the expression of the early activation marker CD69 in
LPS-treated PMUs and, upon in vivo challenge, in splenic
MUs, T-cells, DCs and NK cells, but not in B-cells. In accor-dance with previous ﬁndings IFN-I are important inducers of
CD69 cell surface expression. CD69 is associated with diﬀerent
NK cell activation pathways [26] and has an impact on T-cell
proliferation and activation [27]. The role of CD69 in the
endotoxin shock remains to be elucidated. Nevertheless, it
seems conceivable that the diminished early immune cell acti-
vation via CD69 in Tyk2/ mice contributes to the reduced
cytokine production and response observed during the devel-
opment of the LPS-induced septic shock.
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